1,044
Participants
Start Date
November 30, 2010
Primary Completion Date
November 30, 2012
Study Completion Date
November 30, 2013
Paliperidone Palmitate
50 - 150 mg eq. every 30 days
Salzburg
Brussels
Dave
Diest
Kruishoutem
Liège
Melle
Roeselare
Sint-Denijs-Westrem
Tournai
Rijeka
Zagreb
Aalborg
København V
Randers
Tallinn
Bar-le-Duc
Bron
Clermont-Ferrand
Dax
Dijon
Dole
Lille
Limoges
Montpellier
Nîmes
Paris
Saint-Nazaire
Saint-Priest-en-Jarez
Strasbourg
Villejuif
Bad Saarow
Berlin
Bielefeld
Bochum
Butzbach
Dresden
Gelsenkirchen
Greifswald
Hamburg
Heidelberg
Königsbrück
Mittweida
Oranienburg
Regensburg
Stralsund
Ulm
Westerstede
Würzburg
Arta
Athens
Katerini
Thessaloniki
Thessalonikis
Budapest
Debrecen
Pécs
Pardesiyya
Ramat Gan
Tirat Hacarmel
Daugavpils
Jelgava
Liepāja
Riga
Sigulda
Strenči
Panevezys
Vilnius
Groningen
Almada
Angra do Heroísmo
Castelo Viegas
Coimbra
Lisbon
Porto
Alcorcón
Alicante
Barcelona
Burgos
Coslada
Elche
Madrid
Málaga
Palma de Mallorca
Sant Boi de Llobregat
Sant Joan d'Alacant
Santa Coloma de Gramenet
Vigo
Zamora
Zaragoza
Gothenburg
Lidingö
Malmo
Mölndal
Spånga
Upplands Vasby
Solothurn
Zurich
Ankara
Diyarbakır
Gaziantep
Istanbul
Izmir
Trabzon
Dnipro
Donetsk
Hlevakha
Ivano-Frankivsk
Kharkiv
Kiev
Lviv
Odesa
Poltava
Simferopol
Smila
Ternopil
Uzhhorod
Yevpatoria
Barnet
Birmingham
Cambridge
Coventry
Darlington
Lincoln
London
Prescott
Stoke-on-Trent
Lead Sponsor
Janssen-Cilag International NV
INDUSTRY